In vitro and in vivo assays demonstrated that inhibition of PVT1 achieved by PVT1 ASOs could inhibit EAC cell proliferation, invasion, reduced CSC-related characteristics, and delayed tumor growth. The gene discussed is PVT1; the disease is neoplasm.